# ANBIO BIOTECHNOLOGY LTD SHS CL A

ANBIO BIOTECHNOLOGY LTD SHS CL A is a security (CUSIP G0367B105) tracked across SEC portfolio filings. 8 institutional managers reported $1.3M on Form 13F as of 2026-06-30.

## Summary

- Issuer: ANBIO BIOTECHNOLOGY LTD
- Class: SHS CL A
- CUSIP: G0367B105
- 13F holders: 8
- 13F value: $1.3M
- 13F period: 2026-06-30
- N-PORT fund positions: 0

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [GEODE CAPITAL MANAGEMENT, LLC](https://search.stillhousedata.com/firm/115504) | BOSTON, MA | $662K | 25,763 |
| BNP PARIBAS ARBITRAGE, SNC | PARIS, I0 | $267K | 10,400 |
| MORGAN STANLEY | NEW YORK, NY | $189K | 7,338 |
| UBS Group AG | Zurich, V8 | $163K | 6,339 |
| WELLS FARGO & COMPANY/MN | SAN FRANCISCO, CA | $3K | 100 |
| [EverSource Wealth Advisors, LLC](https://search.stillhousedata.com/firm/286340) | BIRMINGHAM, AL | $3K | 187 |
| [Bare Financial Services, Inc](https://search.stillhousedata.com/firm/328043) | GAP, PA | $206 | 15 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/G0367B105.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.